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Surgical intervention is often required to restore knee instability in patients with anterior cruciate ligament
(ACL) injury. The most commonly used grafts for ACL reconstruction are tendon autografts or allografts. These
current options, however, have shown failure rates requiring revision and continued instability in the long term.
The mismatched biomechanical properties of the current tendon grafts compared with native ACL tissue are
thought to contribute to these poor outcomes and potential risk of early onset osteoarthritis. As a possible
solution to these issues, our laboratory has fabricated tissue-engineered ligament constructs that exhibit
structural and functional properties similar to those of native ACL tissue after 6 months implantation. In
addition, these tissue-engineered grafts achieve vascular and neural development that exceeds those of patellar
tendon grafts. However, the utility of our tissue-engineered grafts is limited by the labor-intensive method
required to produce the constructs and the need to use the constructs fresh, directly from the cell culturing
system. Ideally, these constructs would be fabricated and stored until needed. Thus, in this study, we inves-
tigated the efficacy of freezing our tissue-engineered constructs as a method of preservation before use for ACL
reconstruction. We hypothesized that frozen constructs would have similar histological and biomechanical
outcomes compared with our fresh model. Our results showed that 6 months postimplantation as an ACL
replacement graft, both our tissue-engineered fresh and frozen grafts demonstrated similar mechanical and
histological outcomes, indicating that freezing is a suitable method for preserving and storing our graft before
ACL reconstruction. The ability to use frozen constructs significantly increases the versatility of our graft
technology expanding the clinical utility of our graft.
Introduction
Anterior cruciate ligament (ACL) reconstructionsurgeries are one of the most commonly performed or-
thopedic procedures with over 100,000 patients undergoing
the surgery each year in the United States.1 Cumulative fail-
ure rates of ACL reconstruction to restore knee joint stability
suggest that at least one in nine patients will experience re-
rupture or clinical failure in the long term.2 Limitations as-
sociated with current graft choices are compounded by the
mismatched biomechanical properties exhibited by all tendon
grafts in comparison with the native ACL.
Tissue engineering strategies are being developed to po-
tentially address the shortcomings of the current graft op-
tions. Current tissue engineering techniques, however, focus
on the development of a biological or synthetic scaffold to
provide strength and an environment suitable for cellular
growth either in vitro or in vivo. To date, no scaffold tech-
nology exists that is able to withstand the multidirectional
mechanical forces of a native ACL and has the necessary
biocompatibility and biodegradability qualities needed for
ACL reconstruction.3,4
Our laboratory has previously developed a method of
tissue engineering three-dimensional (3D) multiphasic
bone–ligament–bone (BLB) constructs from bone marrow
stromal cells (BMSCs). During in vitro tissue engineering,
the BMSCs form their own extracellular matrix (ECM)
eliminating the need for an exogenous scaffold. We have
shown that after 6 months in vivo, these engineered scaf-
foldless BLB constructs undergo significant remodeling to
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develop similar mechanical and morphological properties to
those of native ACLs and are capable of inducing vascular
and neural development.5 These results show that our BLB
constructs offer a promising alternative technology for ACL
reconstruction.
A limitation of tissue engineering is the time necessary to
fabricate engineered tissue in vitro and the task of getting
freshly engineered tissues to the patient. It takes*2–3 weeks
to culture and expand freshly isolated BMSCs to obtain the
necessary amount of cells required to fabricate a construct. An
additional 2 weeks is required after 3D formation to mature
the construct in vitro to improve fusion between tissue in-
terfaces and increase tensile strength before implantation.
The total time required from bone marrow isolation to an
implantable 3D construct is *6–7 weeks. Recent studies
suggest that the timing of ACL repair after injury is critical
and that early intervention ismost effective.2,6–8 It is therefore
necessary to develop technologies for graft preservation and
to have the option of an off-the-shelf allograft ligament.
Several freezing methods exist for tissue preservation,
including deep-freezing, cryopreservation, vitrification (ice-
free cryopreservation), and freeze-drying. Although the other
methods listed may have better cell preservation outcomes,
deep-freezing is the simplest and most commonly used
method with reported tissue storage times exceeding 3–5
years at - 80C.3,4,9,10 Thus, for this study, we chose to in-
vestigate deep-freezing as a method to preserve and store our
constructs.
The purpose of this study was to use our sheep ACL
reconstruction model to validate the deep-freezing preser-
vation method by comparing the histological and biome-
chanical outcomes of the frozen grafts with fresh grafts in a
6-month recovery study. In vitro construct morphology and
viability was also assessed at various time points post 3D
formation to document the extensive in vitro remodeling and
to identify an optimal point for freezing the graft. We hy-
pothesized that the structural and functional outcomes of the
frozen and fresh models would be similar after 6 months of
implantation, indicating that frozen grafts would be a viable
off-the-shelf option for ACL reconstruction.
Materials and Methods
Animal care
BMSCs were harvested from marrow aspirations from
adult female Black Suffolk sheep to fabricate our tissue-
engineered constructs for use as grafts in our previously de-
scribed model for sheep ACL reconstruction.5,11 Animals
were acclimated to the Unit for Laboratory Animal Medicine
(ULAM) husbandry facilities at the University of Michigan
for at least 1 week before any procedure. Sheep were given
access to food and water ad libitum. All animal care and
animal surgeries were performed in accordance with The
Guide for the Care and Use of Laboratory Animals,12 and the
experimental protocol was approved by the University
Committee for the Use and Care of Animals at the University
of Michigan.
Preparation of cell culture supplies
The media used in this experiment have been previously
described.5 All solutions and media were prepared and
stored at 4C and were warmed to 37C in a heated bead
bath before use. Briefly, the growth medium (GM) consisted
of 78% Dulbecco’s modified Eagle medium (DMEM; Gibco,
Grand Island, NY) with 20% fetal bovine serum (Gibco,
Grand Island, NY), 2% antibiotic anti-mycotic (ABAM;
Gibco), 6 ng/mL basic fibroblast growth factor (Peprotech,
Rocky Hill, NJ), 0.13mg/mL ascorbic acid-2-phosphotase
(Sigma-Aldrich, St. Louis, MO), and 0.05mg/mL L-proline
(Sigma-Aldrich); the differentiation medium (DM) con-
sisted of 91% DMEM, 7% horse serum albumin (Gibco),
2% ABAM, 0.13mg/mL asc-2-phos, 0.05mg/mL L-proline,
and 2 ng/mL transforming growth factor beta (Peprotech).
For the culture of bone cells, 10 - 8 M dexamethasone
(Sigma-Aldrich) was added to the GM and DM.13
Construct dishes were prepared as described previously5
to house and constrain the formed 3D constructs. Briefly,
100-mm-diameter cell culture plates were filled with 12mL
Sylgard (type 184 silicon elastomer; Dow Chemical Corp.,
Midland, MI) and allowed to cure for 3 weeks at room
temperature. Before use, plates were decontaminated with
UV light (wavelength 253.7 nm) for 60min and rinsed with
70% EtOH and Dulbecco’s phosphate buffered saline
(DPBS; Gibco, Grand Island, NY).
Isolation and expansion of BMSCs
Bone marrow was aspirated from the iliac crest of a sheep
using a Monoject Illinois needle (Sherwood Medical Com-
pany, St. Louis, MO) with the animal under general anes-
thesia. The collected marrow aspirate was filtered through a
100-mm filter to remove solid debris and combined into a
total volume of 15mL with an equivalent volume of DPBS
added. A layer of 15mL Ficoll-Paque Premium (MNC; GE
Healthcare, Munich, Germany) was carefully added on top
of the aspirate and the solution was centrifuged (AccuSpin
FR; Beckman Coulter, Inc., Fullerton, CA) at room tem-
perature at 600 g for 30min to separate the aspirate com-
ponents by density. The upper layer of plasma was removed
and the mesenchymal cells contained in the middle mono-
nuclear cell layer were transferred into a new conical filled
with DPBS. The remaining aspirate contents of the conical
were discarded. The purified isolate was then centrifuged at
500 g for 10min and the supernatant removed. An equiva-
lent volume to the pellet of the ACK lysing buffer (Gibco)
was added and mixed for 30 s to lyse any remaining red
blood cells. The conical was then filled with DPBS and
centrifuged at 400 g for 5min to wash the cells. After the
supernatant was removed, the pellet was resuspended in
20mL GM and a cell count was taken. Cells were then
plated at 40,000–60,000 cells/cm2 in cell culture dishes.
Fabrication of BLBs
Using previously described methods, the BMSCs were
expanded into ligament and bone lineages.5,11,13. Briefly,
passage-3 cells in the ligament pathway and passage-4 cells
in the bone pathway were seeded at a density of 21,000
cells/cm2 and switched to the DM after 8 days of plating.
After 2 days in the DM, the bone monolayers were rolled
with sterile tweezers into a tube shape and transferred to
Sylgard plates. After 1 to 2 additional days, the bone con-
structs were then ready to be incorporated into a ligament
monolayer to create our BLB. Each confluent ligament
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monolayer was removed intact from the cell culture plate
surface and transferred to Sylgard plates and pinned back
into a single layer. Bone constructs were then pinned on
each end of the ligament monolayer and subsequently sur-
rounded by ligament tissue. The length of the BLB was
adjusted with minutien pins to the desired length of *60–
75mm and comprised at least a 30-mm ligament portion and
two 15-mm bone ends. Four of these constructs were placed
side-by-side and allowed to fuse. The DM was changed
every 2–3 days. After 2 weeks of formation, two fused sets
of four constructs were combined for an implantation width
of *4–5mm at the ligament region. After an additional 1
week in culture, the fully formed BLB was ready for im-
plantation. All tissues were constrained using minutien pins
at set distances at all times during the 3D culture. Before
implanting, the bone ends of the BLB were threaded with a
nonabsorbable 5-0 silk suture to allow for passage into the
bone tunnel and fixation onto the periosteum.
Fully formed frozen BLBs stored in the DM were pre-
pared by sealing the lid of a Sylgard dish with paraffin film.
The entire dish was then placed into an - 80C freezer for a
minimum of 1 h to ensure that the construct was completely
frozen. Before surgical implantation, plates were retrieved
from the freezer and allowed to thaw in a 37C bead bath.
After complete thawing of the construct, the paraffin film
was removed and plates were stored in a cell culture incu-
bator at 37C until implantation.
Histological analysis of in vitro engineered constructs
Constructs were removed from the culture at designated
time points and fixed with paraformaldehyde for 1 h at room
temperature, 15% sucrose for 2–3 h rocking at room tem-
perature, and then 30% sucrose overnight rocking at 4C.
Following fixation, constructs were placed into a tissue
freezing medium (Triangle Biomedical Sciences, Durham,
NC), frozen with dry ice, and stored until needed at - 80C.
Frozen samples were sliced in either cross sections or lon-
gitudinally using a Microm HM 500 cryostat system (Hei-
delberg, Germany) to a thickness of 14 mm and were placed
onto Superfrost Plus microscopy slides. For determination
of collagen, sections were stained with Picrosirius Red.
Sections were also stained with hematoxylin and eosin
(H&E) for general morphology characteristics.
For immunohistochemical staining, sections were rinsed
thrice for 5min each with phosphate-buffered saline (PBS)
containing PBS-0.1% Triton X-100 (PBST; Sigma-Aldrich).
Sections were blocked for 30min with PBST containing
5% donkey serum (PBST-S) at room temperature in a hu-
midified chamber, and incubated overnight at 4C with
the primary antibody 1:400 rabbit anti-Caspase-3 (Abcam,
Cambridge, MA). After three washes in PBST, the slides
were incubated for 2 h with the secondary antibody 1:1000
Alexa555 anti-rabbit (Invitrogen, Carlsbad, CA), rinsed
thrice in PBST, and mounted with Prolong Gold Antifade
reagent with DAPI (Molecular Probes, Eugene, OR). The
sections were examined and photographed with an Olympus
BX-51 fluorescent microscope.
Surgical procedure
ACL reconstructions were performed arthroscopically
based on a previously described procedure.5 Briefly, after
induction of general anesthesia and preparation of the sur-
gical site, the native ACL of the left limb was removed with
remnants of the stump on both the femur and tibia used to
aid in anatomical positioning of the BLB. Drill guides were
used to position Steinmann pins for precise placement at the
center of the tibial and femoral footprints. Bone tunnels (5–
6mm) were drilled using cannulated reamers over the pins.
The BLB was then passed through the bone tunnels using
sutures until the threaded bone ends of the BLB were not vis-
ible arthroscopically in the intra-articular space. The proximal
and distal ends were then secured with sutures to the perios-
teum. Incisions were closed with staples and the entire surgical
site was sprayed with Alushield (Neogen Corp., Lansing, MI).
The contralateral (right) limb served as a control.Animalswere
monitored daily at the ULAM facility for 2 weeks, after which
staples were removed and the animals were sent to a large
outdoor pen to allow greater mobility.
Explantation
After a 6-month implantation, both the experimental and
contralateral knees were explanted for morphological and
mechanical analyses. Following euthanasia, the knee was
harvested by removing the tibia and femur and taken for
mechanical testing. Anterior drawer testing of the knee at 45
degrees was performed with the knee capsule intact. The
knee was subsequently dissected to the BLB or contralateral
ACL (C-ACL). For visualization of the entire graft during
uniaxial tensile testing, the medial condyle was carefully
removed. Following anterior drawer and uniaxial tensile
testing, the BLB and C-ACL were resected from their tibial
and femoral bone insertions and harvested for histology.
Histological analysis of explanted BLB and C-ACL
For histological preparation of explanted tissues, samples
were fixed in 10% neutral buffered formalin for 8 days and
stored in 70% ethanol at 4C until processing. Each tissue
was sectioned in a microtome (Leica RM 2155) at 6 mm,
placed onto Superfrost Plus microscopy slides, and placed in
a 60C oven for 1 h to dry. For morphological characteristics,
sections were stained with H&E. Immunohistochemistry
(IHC) staining with specific antibodies was performed to
detect the presence of elastin and collagen type 1.
To deparaffinize the slides with paraffin sections for IHC,
slides were washed thrice in xylene for 3min, twice in 100%
ethanol for 2min, twice in 95% ethanol for 2min, and once
in 70% ethanol for 2min. Following deparaffinization,
slides were washed in PBST for 15min at room temperature.
Using a hydrophobic pen, sections were circled for blocking
and antibody staining. Sections were covered in a blocking
solution containing PBST with 3% bovine serum albumin
(Sigma-Aldrich) for 30min at room temperature. Primary
antibodies were diluted in the blocking solution and added
to the sections and incubated overnight at 4C in a hydration
chamber. The dilutions of the primary antibodies used were
as follows: 1:35 of rabbit anti-elastin (#AB2039; Millipore,
Billerica, MA); and 1:100 of rabbit anti-collagen type I
(#AB292; Abcam). Slides were then washed for 5min in
PBST at room temperature thrice for a total of 15min.
Secondary antibodies were diluted at 1:500 in the blocking
solution in the dark and added to the sections. The slides
were kept in a hydration chamber and incubated at room
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temperature for 2.5 h. The slides were then washed for
15min in PBS at room temperature thrice for a total of
45min. Nuclei were stained using Prolong Gold with DAPI
(Sigma-Aldrich) to each section. Slides were then covered
with a coverslip and incubated overnight at room tempera-
ture before imaging with an Olympus BX-51 microscope.
Knee laxity testing
Knee laxity was measured using a custom-designed an-
terior drawer tester.14 The bones were potted in grips using a
polymer that became malleable when heated and hardened
to its conformed shape when allowed to cool. The bone and
hardened polymer were secured with two ¼¢¢-20 screws in
the grips and mounted onto an MTS 810 servohydraulic test
system with a 25 kN load cell. Ink markings were placed at
a known distance onto the femur and tibia grips for dis-
placement tracking. The test comprised a 0.5mm/s exten-
sion until a 50N force was achieved. Images were collected
with a Grasshopper IEEE-1394b digital camera (Point Grey,
British Columbia, CA), and analysis for displacement was
determined using MetaMorph software.
Uniaxial testing
Knee tissue was further dissected away, leaving only the
BLB or C-ACL attached at both tibial and femoral inser-
tions. The length of the ligament as well as the width and
thickness of the proximal, middle, and distal regions were
measured and recorded. The cross-sectional areas from these
three locations were averaged and used as the representative
area for stress calculations. The knee was repositioned for a
flexion angle of 30 degrees by fixing the tibia and femur grips
at 90 and 60 degrees, respectively, in the sagittal plane to put
the ligament in a uniaxial loading configuration. Graphite
powder was blown onto the specimen to create a surface
pattern for optical displacement measurement using digital
image correlation (DIC) to compute full-field strain contours.
Uniaxial tension tests at a strain rate of 0.05/s for a loading
time of 7.5 s were then conducted on the BLB and ACL
specimens to obtain the stiffness using previously developed
testing protocols.5 A Photron high-speed camera was used for
synchronized force and image acquisition with a custom-de-
veloped LabView program. The load–unload cycle for each
specimen was run in triplicate. VIC-2D Software (Correlated
Solutions, Columbia, SC) was used for DIC analysis.
Statistical analysis
Comparisons among the three groups were done using
one-way analysis of variance (ANOVA) with Tukey’s post-
hoc test. A p-value < 0.05 for all statistical tests was con-
sidered significant. All data are reported as mean – standard
deviation.
Results
Histological evaluation of in vitro engineered ligament
tissue over time in culture
To examine general morphological characteristics of the
engineered ligament constructs over time in vitro, staining
with H&E was performed. H&E-stained cross sections
through the center of fresh ligament constructs displayed
viable cells at 48 h, 1, 2, and 3 weeks following roll up of the
monolayer (Fig. 1A–D). At 48 h, following roll up of the
monolayer, the center of the construct was not immediately
fused and the nuclei were densely packed (Fig. 1A). At the
1-week time point, the construct was fully fused and the
nuclei were densely packed (Fig. 1B). By 2 weeks in cul-
ture, the construct had reorganized into a dense 3D structure,
and the nuclei were less densely packed together (Fig. 1C).
At 3 weeks, extensive remodeling had occurred and the
nuclei remained less densely packed together (Fig. 1D). A
fibrotic outer layer similar to that observed in native liga-
ment was observed around the outer surface at the construct
from 48 h to 2 weeks in vitro, but had disappeared by 3
weeks in vitro (Fig. 1A–D).
Picrosirius red staining was performed to assess the
presence of collagen. Figure 1E–H shows stained cross
sections at the center of the ligament constructs at 48 h, 1, 2,
and 3 weeks following roll up of the monolayer with col-
lagen indicated in red. Collagen was present in the construct
at 48 h following roll up of the monolayer; however, the
layers of the construct remained distinct, indicating that they
had not yet fused (Fig. 1E). By 1 week, extensive re-
modeling had occurred, and the dense bands of collagen
began to interweave through the cross sections of the con-
struct (Fig. 1F). By 2 weeks, the construct continued to
remodel and the collagen was organized into dense irregular
bands throughout the construct that appeared to have an
increase in surface area (Fig. 1G), which increased in
complexity by 3 weeks in culture (Fig. 1H). Overall, con-
struct remodeling was extensive with the complexity and
surface area of dense collagen bands increasing with time
in vitro from 48 h to 3 weeks in culture.
To assess cell death or apoptosis, immunohistochemical
staining was performed with an antibody specific to caspase-3
at 48 h, 1, 2, and 3 weeks following roll up of the monolayer
for qualitative analysis (Fig. 2). The cross sections through the
center of the ligament constructs at 48 h in culture were
positive for caspase-3 in the central region of the construct
(Fig. 2A, C). DAPI staining of the ligament constructs showed
that at 48h in vitro the nuclei were densely packed together
(Fig. 2B). At 1 week, caspase-3 was expressed not only in the
central region but also along the outer regions of the construct
(Fig. 2D, F). By 2 weeks, there appeared to be a pronounced
decrease in apoptosis as shown by a marked reduction of
caspase-3 throughout the construct (Fig. 2G, I), and the nuclei
were less densely packed together (Fig. 2H). At 3 weeks
in vitro, caspase-3 expression was still observed (Fig. 2I).
Analysis of structure, vascularization, innervation,
and elastin of the explanted BLBs
After 6 months in vivo, explanted frozen BLBs achieved an
average length of 18.1–3.3mm with explanted fresh BLBs
reaching 18.5–1.2mm (Fig. 3A). The average cross-sectional
areas (CSAs) of frozen BLBs were 33.3–9.5mm2 and fresh
BLB CSAs were 29.7–10.5mm2 (Fig. 3B). The average
length and CSA of the C-ACLs were 21.4–3.1mm and
39.1–9.2mm,2 respectively. One-way ANOVA showed no
statistically significant difference (p>0.05) between the aver-
age lengths F(2,25)=2.3 and CSAs F(2,25)=1.5 of the groups.
General morphology of the explanted frozen and fresh
BLBs showed similar characteristics. H&E sections showed
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the formation of a ligamentous crimp-like pattern with fibers
arranged along the long axis of the tissue (Fig. 4) as well as
the formation of vasculature and innervation seen in the
cross section (Fig. 5). Immunohistochemical staining showed
similar collagen and elastin deposition compared with the
C-ACL.
Knee laxity
The knee laxity for the frozen BLB knees averaged
1.9 – 0.4mm (n = 6), while that of the fresh BLB knees was
1.9 – 0.4mm (n = 4). The C-ACL knee laxity averaged
0.5 – 0.3mm (n = 15) (Fig. 6). One-way ANOVA showed no
significant difference between frozen and fresh knee laxity
( p > 0.05), but both groups had significantly increased laxity
( p < 0.001) compared with the C-ACL knees, F(2,22) = 11.9.
Modulus analysis of BLB
The tangent modulus (the slope of the stress–strain curve
at a specified strain range) for the frozen BLB group aver-
aged 42 – 7MPa (n = 6), whereas the tangent modulus of the
fresh BLBs averaged 35– 13MPa (n= 3) at a strain range of
0.04–0.10 (Fig. 7). The tangent modulus data indicated no
significant differences between the two graft types
( p > 0.05). Both grafts achieved *23–30% of the average
C-ACL modulus, which was 158 – 32MPa (n = 12) at a
strain range of 0.04–0.10.
Discussion
Our tissue-engineered BLBs are a promising solution to
address the need for a better ACL replacement graft and
offers advantages over currently used tendon grafts.5 To
date, major limitations to our BLB technology are the graft’s
relatively short shelf life, the requirement that the graft must
be kept fresh, and the need to use the graft directly from a
cell culture system. This study sought to investigate the
efficacy of our grafts for ACL reconstruction following a
simple deep-freezing preservation method by comparing the
outcomes of the frozen grafts to our previously established
fresh allografts in a 6-month recovery study. Our results
showed that at 6 months postimplantation as an ACL
FIG. 1. Characterization of cross sections
taken from the center of engineered liga-
ment constructs using H&E (A–D) and Pi-
crosirius Red (E–H) with time in vitro. At
48 h, the center of the construct was not
fused (A). By 2 weeks, the construct had
reorganized into a dense three-dimensional
structure (C). A fibrotic outer layer was
observed around the outer surface at the
construct from 48 h to 2 weeks in vitro, but
had disappeared by 3 weeks in vitro (A–D).
Picrosirius red staining revealed that colla-
gen is present in the construct at 48 h fol-
lowing roll up of the monolayer (E). The
complexity and overall expression of colla-
gen throughout the construct appeared to
increase with time in vitro, with dense rib-
bons of collagen forming by 1 week in vitro
(F). All images were taken at 20· magni-
fication with scale bars indicating 200 mm.
H&E, hematoxylin and eosin. Color images
available online at www.liebertpub.com/tec
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replacement graft, both our tissue-engineered fresh and
frozen grafts demonstrated similar mechanical and histo-
logical outcomes, indicating that deep-freezing is a suitable
method for preserving and storing our graft before ACL
reconstruction. The ability to use frozen constructs signifi-
cantly increases the versatility of our graft technology ex-
panding the clinical utility of our graft.
Fabrication of BLBs requires *4–5 weeks for induction
of BMSCs to ligament and bone lineages, formation of ro-
bust monolayers, and coculture of the bone and ligament
tissues into a 3D configuration. An additional 2 weeks is
needed in vitro for the BLB to condense and fuse into a
uniform and robust 3D construct. We have demonstrated
that our BLB continues to remodel significantly in the 2
weeks in vitro that the constructs are left to fuse. The dense
collagen bands and decreased cellularity seen at 2-week and
3-week fusion time points using Picrosirius Red and H&E/
DAPI-stained cross sections suggest that the constructs
FIG. 2. Cellularity and
apoptosis of engineered lig-
ament constructs. Immuno-
histochemical staining of
cross sections of engineered
ligament constructs at 48 h,
1, 2, and 3 weeks in vitro
using the apoptosis marker
caspase-3 (red) and DAPI
(blue). Caspase-3 was ex-
pressed in the middle region
of the construct at 48 h (A,
C), throughout the construct
at 1 week (D, F), and
decreased in expression
throughout the and construct
by 2 and 3 weeks (G, I, J, L).
Forty-eight-hour and 1 week
constructs had densely
packed nuclei (B, E). By
2 weeks in vitro, nuclei were
less densely packed (H)
and the trend continued at
3 weeks in vitro (K). All
images were taken at 20·
magnification with scale bars
indicating 200 mm. Color
images available online at
www.liebertpub.com/tec
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FIG. 3. Comparisons of length (A) and cross-sectional area (B) of C-ACL, explanted fresh BLB, and frozen BLB after 6
months in vivo. Values are mean – standard deviation. There were no significant differences found in the length and cross-
sectional area of the C-ACL, fresh BLB, and frozen BLB. BLB, bone–ligament–bone; C-ACL, contralateral anterior
cruciate ligament.
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increase collagen deposition and advance ECM formation at
these time points compared with earlier in formation. Apop-
totic cells were observed at both the 2-week and 3-week time
points suggesting that the BLB continues to remodel, possibly
removing cells to accommodate the increased ECM secretion.
Thus, it was decided that the optimal time for freezing would
be at least 2 weeks after formation to allow for the achieve-
ment of favorable morphological and mechanical properties
and reduce the risk of losing the construct due to breakage
from the pins. Freezing the constructs at less than 2 weeks
resulted in a construct that was not sufficiently fused for
implantation.
The frozen and fresh BLBs had similar outcomes as grafts
for ACL reconstruction. After 6 months in vivo, frozen and
fresh BLBs both increased in size to that observed in the C-
ACLs. Compared with each other, frozen and fresh BLB
grafts showed similar knee laxity and had similar mechan-
ical moduli. However, compared with the C-ACL, both
frozen and fresh BLB knees had increased laxity and the
FIG. 4. Longitudinal sections of
C-ACL and explanted BLB (fresh/
frozen) after 6 months in vivo. H&E
staining (A–C) was used to ascer-
tain general structure and morphol-
ogy. Immunohistochemical staining
for Elastin (D–F) and type I colla-
gen (G–I) showed positive staining
in both fresh (E, H) and frozen (F, I)
with organization and staining
showing similarities to C-ACL (D,
G). All images were taken at
40· magnification with scale bars
indicating 100 mm. Color images
available online at www.liebertpub
.com/tec
FIG. 5. Cross sections of C-ACL and explanted BLB
(fresh/frozen) after 6 months in vivo. H&E images (A–C) at
40 · showed pronounced vasculature confirmed by CD31
(D–F) antibody staining in both fresh (B, E) and frozen
BLBs (C, F), indicating tissue regeneration. Color images
available online at www.liebertpub.com/tec
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FIG. 6. Knee laxity of C-ACL and explanted BLB (fresh/
frozen) after 6 months in vivo. No significant differences were
seen between the fresh and frozenBLB knee laxities; however,
they were both significantly more lax than the C-ACL. Thick
bars represent the mean, and error bars indicate standard de-
viation. Asterisks (*) denote significance from C-ACL.
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dissected grafts achieved *30% of the mechanical modu-
lus. Histological evaluation indicated the presence of a lig-
amentous crimp pattern similar to the C-ACL and the
formation of vascularization and innervation in both frozen
and fresh BLBs. These findings suggest that the frozen BLB
is capable of mounting a regenerative response approximat-
ing those found with fresh BLBs. In agreement with our
previous studies,5 no systemic immune responses were noted.
Due to the high cost and resource demands of this project, it
was necessary to gather mechanical and histological assess-
ments on the same tissue. Mechanical tests were performed
first at a conservative level to prevent damage to the tissue. As
a result, there is a high variation in the selection of the strain
region from the linear portion of the stress–strain curve used
to calculate the tangent modulus.
Traditional methods of freezing, including the deep-
freezing method used in this study, can cause ice crystal
formation that can distort and possibly damage the ECM.10,15
These concerns were shown10 to not be as significant in the
tissue-engineered ECM containing high densities of elastin
and collagen such as our BLBs, which may explain the ab-
sence of a dramatic loss in structural ormechanical phenotype
after freezing and thawing. Other preservation methods may
prove superior for the maintenance of cell viability, but the
simplicity and success of the deep-freezing method deem this
method an optimal preservation strategy for our ligament
graft. Future studies will need to be done to determine the
viability and efficacy of the frozen constructs after long-term
storage to determine the true shelf life of the construct using
this preservation method and establish criteria for product
expiration.
Additional work is also needed to help elucidate the re-
generative and remodeling processes that are occurring in
the BLB grafts in vivo. It is evident from the results of this
work along with numerous other studies utilizing acellu-
larized or scaffold-only grafts that live cells are not neces-
sarily required to induce these responses.16 It is possible that
our tissue-engineered ligament technology produces the
most biomimetic structure for endogenous ACL regenera-
tion. Viable cells were also found to have negligible con-
tribution to tendon and ligament graft biomechanics
compared with acellularized grafts in vitro.17 Therefore,
lysing the cells from our BLBs after maturation to the de-
sired level in vitro will allow us to bypass the physical
conditions needed for maintaining viable cells without
compromising the BLB’s structural integrity. It is important
to consider that although we are lysing cells by deep-
freezing, we are not necessarily removing all cellular DNA
or debris. The regenerative response that we observed could
in fact be due to residual cellular components within the
frozen graft. An alternative explanation is that only the
ECM of the graft is needed. Thus, further experiments in-
vestigating host cell interactions with the graft ECM and
pathways of cellular migration, including local cytokine
expressions, will be useful to determine the processes of
cellular migration and remodeling of the graft toward native
ligament. It would be advantageous if only the ECM was
necessary for graft success, as this would obviate the reg-
ulatory hurdles that would otherwise be required for grafts
with viable cells. Further studies should be done to deter-
mine the efficacy of various techniques to clear cell material
from the graft and their responses in vivo to consider this
regulatory route.
In this study, we have validated the use of deep-freezing
as a means for short-term BLB graft preservation. We have
shown that our constructs actively remodel in vitro after
3D formation with collagen alignment and deposition in-
creasing in levels after 2–3 weeks. After freezing and
thawing, the BLBs maintained their structure and were
implanted successfully for ACL reconstruction. Both fro-
zen and fresh BLBs exhibited similar biomechanical and
histological outcomes after 6 months of implantation, re-
modeling in vivo to a more mature phenotype that resem-
bled native ACL. Thus, the use of frozen BLBs is a viable
method for construct preservation and circumvents the
need for viable cells. This knowledge expands our graft
fabrication technology and allows for the production of a
stock inventory of frozen ligament grafts available for use
at times of clinical need, thereby progressing the transition
of the current technology toward large-scale manufacturing
and clinical translation.
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